From: Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands
Parameter
Type of distribution
Source
Transition probabilities
Weibull distribution
Real-world data and RCT
Costs
γ distribution
Real-world data
Utilities
β distribution
RCT